Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers
Ania Cabrales(Centro de Ingeniería Genética y Biotecnología), Luis Javier González(Centro de Ingeniería Genética y Biotecnología), Eduardo Fernández(University of Havana), Gerardo Guillén(Hunan City University), Osvaldo Reyes, Francisco Hernández‐Bernal(Centro de Ingeniería Genética y Biotecnología), Gabrìel Padrón, Carmen Valenzuela(Center of Molecular Immunology (Cuba)), Vladimir Besada, Ariadna Hernández(Centro de Ingeniería Genética y Biotecnología), Jorge Berlanga(Centro de Ingeniería Genética y Biotecnología), Idrián García García(Centro de Ingeniería Genética y Biotecnología), Jeovanis Gil(Lund University)
Cited by 15
Related Papers
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients
|MEDICC Review|2021|139
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
|Frontiers in Endocrinology|2020|134